Regulation of pentraxin-3 by antioxidants
Open Access
- 1 December 2009
- journal article
- research article
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 103 (6) , 833-839
Abstract
Pentraxin-3 (PTX3) may be a useful biomarker in sepsis, but its regulatory mechanisms are still unclear. Oxidative stress is well defined in patients with sepsis and has a role in regulation of inflammatory pathways which may include PTX3. We undertook an in vitro study of the effect of antioxidants on regulation of PTX3 in endothelial cells combined with a prospective observational pilot study of PTX3 in relation to markers of antioxidant capacity and oxidative stress in patients with sepsis. Human endothelial cells were cultured with lipopolysaccharide 2 microg ml(-1), peptidoglycan G 20 microg ml(-1), tumour necrosis factor (TNF) alpha 10 ng ml(-1), interleukin-1 (IL-1) beta 20 ng ml(-1), or killed Candida albicans yeast cells plus either N-acetylcysteine (NAC) 25 mM, trolox 100 mM, or idebenone 1 microM. Plasma samples were obtained from 15 patients with sepsis and 11 healthy volunteers. PTX3 levels in plasma were higher in patients with sepsis than in healthy people [26 (1-202) ng ml(-1) compared with 6 (1-12) ng ml(-1), P=0.01]. Antioxidant capacity was lower in patients with sepsis than healthy controls [0.99 (0.1-1.7) mM compared with 2.2 (1.3-3.3) mM, P=0.01]. In patients with sepsis, lipid hydroperoxide levels were 3.32 (0.3-10.6) nM and undetectable in controls. We found no relationship between PTX3 and antioxidant capacity or lipid hydroperoxides. Cell expression of PTX3 increased with all inflammatory stimulants but was highest in cells treated with TNFalpha plus IL-1beta. PTX3 concentrations were lower in cells co-treated with antioxidants (all P<0.05), associated with lower nuclear factor kappaB expression for NAC and trolox (P<0.05). PTX3 expression is down-regulated in vitro by antioxidants. Plasma levels of PTX3 are elevated in sepsis but seem to be unrelated to markers of oxidant stress or antioxidant capacity.Keywords
Funding Information
- Medical Research Council, the British Journal of Anaesthesia, and the Intensive Care Society
- Wellcome Trust
This publication has 43 references indexed in Scilit:
- Genome-wide analysis of Candida albicans gene expression patterns during infection of the mammalian kidneyFungal Genetics and Biology, 2009
- Endothelial Cell Stimulation by Candida albicans2009
- Lipoperoxidation and Protein Oxidative Damage Exhibit Different Kinetics During Septic ShockMediators of Inflammation, 2008
- The long pentraxin PTX3 as a link among innate immunity, inflammation, and female fertilityJournal of Leukocyte Biology, 2006
- Increased nuclear factor κB activation in critically ill patients who dieCritical Care Medicine, 2000
- Plasma antioxidant potential in severe sepsisCritical Care Medicine, 1996
- Promoter Structure and Transcriptional Activation of the Murine TSG-14 Gene Encoding a Tumor Necrosis Factor/Interleukin-1-inducible Pentraxin ProteinJournal of Biological Chemistry, 1995
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- Plasma lipid peroxides and antioxidants in human septic shockIntensive Care Medicine, 1991
- Hospital-acquired candidemia. The attributable mortality and excess length of stayArchives of internal medicine (1960), 1988